BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19273297)

  • 1. EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone.
    Ruiz E; Redondo S; Gordillo-Moscoso A; Rodriguez E; Reguillo F; Martinez-Gonzalez J; Tejerina T
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3608-18. PubMed ID: 19273297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1.
    Redondo S; Hristov M; Gümbel D; Tejerina T; Weber C
    Thromb Haemost; 2007 Jun; 97(6):979-87. PubMed ID: 17549301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
    Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
    Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.
    Werner C; Kamani CH; Gensch C; Böhm M; Laufs U
    Diabetes; 2007 Oct; 56(10):2609-15. PubMed ID: 17623816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.
    Gensch C; Clever YP; Werner C; Hanhoun M; Böhm M; Laufs U
    Atherosclerosis; 2007 May; 192(1):67-74. PubMed ID: 16876172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?
    Desouza CV
    J Diabetes Complications; 2013; 27(5):519-25. PubMed ID: 23809765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.
    Martens FM; Visseren FL; de Koning EJ; Rabelink TJ
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):773-8. PubMed ID: 16306801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.
    Spigoni V; Picconi A; Cito M; Ridolfi V; Bonomini S; Casali C; Zavaroni I; Gnudi L; Metra M; Dei Cas A
    PLoS One; 2012; 7(11):e48283. PubMed ID: 23139771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing.
    Liu ZJ; Tian R; An W; Zhuge Y; Li Y; Shao H; Habib B; Livingstone AS; Velazquez OC
    Ann Surg; 2010 Oct; 252(4):625-34. PubMed ID: 20881769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial.
    Esposito K; Maiorino MI; Di Palo C; Gicchino M; Petrizzo M; Bellastella G; Saccomanno F; Giugliano D
    Diabetes Obes Metab; 2011 May; 13(5):439-45. PubMed ID: 21255215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow.
    Zhang HF; Wang L; Yuan HJ; Ma YH; Wang YF; Hu ZY; Su Y; Zhao ZG
    Cell Biol Int; 2013 May; 37(5):430-5. PubMed ID: 23504801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
    Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
    Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells.
    Eriksson L; Erdogdu O; Nyström T; Zhang Q; Sjöholm Å
    Cardiovasc Diabetol; 2012 Mar; 11():27. PubMed ID: 22436702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ; Kang YS; Han SY; Lee MH; Song HK; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones.
    Irat AM; Aslamaci S; Karasu C; Ari N
    J Pharm Pharmacol; 2006 Dec; 58(12):1647-53. PubMed ID: 17331329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.
    Yu X; Chen P; Wang H; Zhu T
    Med Princ Pract; 2013; 22(2):156-60. PubMed ID: 22964975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A
    Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy.
    Bhatwadekar AD; Glenn JV; Li G; Curtis TM; Gardiner TA; Stitt AW
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1232-41. PubMed ID: 18326753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
    Ruiz E; Redondo S; Gordillo-Moscoso A; Tejerina T
    J Pharmacol Exp Ther; 2007 May; 321(2):431-8. PubMed ID: 17267584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone increases adiponectin levels in nondiabetic patients with coronary artery disease.
    Patel SR; Mailloux LM; Coppola JT; Mindrescu C; Staniloae CS
    Coron Artery Dis; 2008 Aug; 19(5):349-53. PubMed ID: 18580598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.